Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Medicover intends to carry out a directed share issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR OTHER MEASURES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF ANY SECURITIES OF MEDICOVER. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.   Medicover AB (publ) (“Medicover” or the “Company”) hereby announces its intention to carry out a directed share issue of Class B shares to Swedish

Tecnotree Corporation - Managers' Transactions - Ketkar

Person subject to the notification requirementName: Ketkar, Sanjay RamPosition: Other senior managerIssuer: Tecnotree CorporationLEI: 743700MRPVYI7ASHCX38 Notification type: INITIAL NOTIFICATIONReference number: 743700MRPVYI7ASHCX38_20200610104514_3____________________________________________ Transaction date: 2020-06-08Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009010227Nature of the transaction: DISPOSAL   Transaction details(1): Volume: 21 Unit price: 0.23 EUR Aggregated transactions(1): Volume: 21 Volume weighted average price:

EAB GROUP PLC: ACQUISITION OF OWN SHARES 10.06.2020

EAB GROUP PLC NOTIFICATION 10.06.2020 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 10.06.2020 Date 10.06.2020Exchange transaction BuyShare class EABAmount 862Average price/share 2.2400 EURHighest price/share 2.2400 EURLowest price/share 2.2400 EURTotal price 1,930.88 EUR The shares held by EAB Group Plc on 10.06.2020: EAB 20,892 On behalf of EAB Group Plc  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please

Change to Citycon’s financial reporting schedule in 2020

CITYCON OYJ   Stock Exchange Release   10 June 2020 at 18:30 hrsCitycon Oyj amends its 2020 financial reporting schedule for its six-month Half-Yearly Report in order to reserve more time for preparing the financial statements and ensuring accuracy and transparency of the fair values of the investment properties in light of the Covid-19 related exceptional circumstances. Citycon will publish its January-June Half-Yearly Report on 4 August 2020 about 9:00 a.m. (previously 10 July 2020). Citycon’s schedule of the financial reporting for the rest of 2020 is the following: · Year 2020 six-

S&P affirms SBB’s investment grade rating BBB- with stable outlook, placing SBB in the strong business profile category

S&P Global Ratings ("S&P") has today affirmed Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”)’s Investment grade rating BBB- with stable outlook and removed SBB from Credit Watch Negative. That means that SBB's new rating is 'BBB-' with stable outlook for ratings on the company and its senior unsecured debt. According to S&P:s rating metrics SBB:s anchor rating is positioned at BBB Flat thanks to revising upward SBB’s business risk profile to “strong”: “We are revising upward our assessment of SBB's business risk profile to strong from satisfactory because we consider its scale and

Delisting of SEMAFO Shares from Nasdaq Stockholm

Montreal, Quebec, June 10, 2020 /CNW/ – SEMAFO Inc. (TSX, OMX: SMF) (“SEMAFO”) today announced that, in conjunction with the anticipated closing of the previously announced Plan of Arrangement transaction with Endeavour Mining Corporation (“Endeavour”), SEMAFO’s application to delist its shares from the Nasdaq Stockholm has been accepted by the Nasdaq Stockholm, conditional on closing of the transaction. As a result, the last day of trading of SEMAFO shares over the Nasdaq Stockholm will be June 24, 2020 with trading suspended effective June 25, 2020. SEMAFO shares will continue to be

Norwegian Energy Company ASA: Share buyback

Reference is made to the stock market announcement on 27 February 2020, where Norwegian Energy Company ASA ("Noreco" or the "Company") announced an initiation of a share buyback programme of up to 160,000 of its own shares. Noreco has on 10 June 2020 purchased 8,772 of its own shares at an average price of NOK 190.0905 per share. After this transaction the Company holds a total of 429,717 own shares. The transaction is completed in accordance with the authorization given by Noreco's general meeting. The information is subject to the disclosure requirements pursuant to section 5 -12

TietoEVRY issues a EUR 300 million bond

TietoEVRY Corporation   PRESS RELEASE  10 June 2020 5.30 pm (EEST) NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. TietoEVRY Corporation issues an unsecured bond with a principal amount of EUR 300 million. The five-year bond matures on 17 June 2025 and carries a fixed annual interest of 2.000 per cent. TietoEVRY will apply for the admission of the bond on the official list of

#20-203 Delisting of certain Derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#20-202 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Betsson AB’s subsidiary Betsson Nordic Ltd warned and sanctioned by the SGA

Betsson Nordic Ltd, an operational subsidiary of Betsson AB which operates the Betsson brand in Sweden, has been issued a warning and a sanction fee of SEK 20 million from the Swedish Gambling Authority (SGA). Betsson Nordic Ltd is considered to have failed to register agents who sold vouchers as well as offered on its webpage, Betsson Mastercards with the perceived scope for potential future customer incentives. Both cases are deemed by the SGA as non-compliant to the Swedish gambling legislation. Both the warning, the sanction and the hefty sanction fee come as a surprise to Betsson AB.

Nel ASA: Receives purchase order for a 2.5 MW PEM electrolyser in Europe

(Oslo, 10 June 2020) Nel Hydrogen US, a subsidiary of Nel ASA (Nel, OSE:NEL), has received a purchase order for a containerized 2.5 megawatt Proton PEM® electrolyzer from a customer in Europe. “We’re proud that our customer decided to go for our Proton PEM® containerized electrolyser solution to produce green hydrogen for mobility applications in Europe, and look forward to support them in their ventures,” says Raymond Schmid, Market Development Director, Nel Hydrogen Electrolyser. The value of the purchase order is in excess of USD 3 million, and the electrolyser is scheduled to

Cyxone enters development agreement with inventor Kalev Kask

Cyxone (publ), a Swedish biotech in autoimmune diseases, announces today that the company has signed an agreement with inventor Dr Kalev Kask. The purpose of the agreement is to initiate a drug development collaboration for the treatment of the symptoms of Covid-19, for which a patent application will be filed.Dr Kalev Kask, a biotech executive and entrepreneur with extensive expertise in drug development, and Cyxone have entered a collaboration to develop a new program for treating patients suffering from symptoms of Covid-19. Cyxone finds the collaboration regarding new therapeutic

Proposal from the Nomination Committee in Solstad Offshore ASA

Reference is made to the stock exchange notice dated June 5[th] including the invitation to the annual general meeting. The recommendation by the nomination committee for the annual general meeting to be held on June 26[th], 2020 at 10:00 (CET), is now available at the company's website and attached to this message. Skudeneshavn, June 10[th], 2020 Solstad Offshore ASAwww.solstad.com This information is subject of the disclosure requirements according to the Norwegian Securities Trading Act section § 5-12.

Arcus ASA: The Annual General Meeting approved a dividend of NOK 1,66 per share

The Annual General Meeting of Arcus ASA approved on 10 June 2020 a dividend of NOK 1,66 per share. Dividend amount: 1.66 per share Declared currency: Norwegian Krone Last day including right: 10 June 2020 Ex-date: 11 June 2020 Record date: 12 June 2020 Payment date: 10 July 2020 Date of approval: 10 June 2020   Arcus ASA Gjelleråsen, 10 June 2020 Group Director Communications and IR Per Bjørkum Telephone: +47 922 55 777 Mail: per.bjorkum@arcus.no.

Cyxone files new patent applications following additional innovation achievements

Cyxone (publ), a Swedish biotech in autoimmune diseases, announces today that the company has filed four patent applications for protection of new innovation achievements. The applications have been filed to relevant patent authorities.With these new patents, Cyxone will have wider protection for the company’s therapeutic scope as well as for the manufacturing and formulation processes. Cyxone is looking into opportunities to file more patent applications in the near future. Cyxone is unable to disclose more information regarding the filed patents at this point. The patents filed

Stena Bulk is presenting a prototype of the next-generation product and chemical tanker – the IMOFlexMAX

Stena Bulk is presenting a prototype of the next-generation product and chemical tanker, the IMOFlexMAX , which will be able to reduce greenhouse gas emissions by more than 25% compared to modern product tankers.[IMOFlexMAX ] The vessel, designed by Stena Bulk to meet the current and future needs of liquid bulk shipping, is a further development of our current IMOIIMAX design; best in class in terms of performance and with a design based on two major objectives – flexibility and efficiency.“The world’s need for reliable, innovative and sustainable transportation of liquid products is

Aptevo Therapeutics and Alligator Bioscience present new preclinical data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit

New Preclinical Data Show That ALG.APV-527 has Potential for a Favorable Safety Profile Does Not Induce Systemic T-cell Activation at High Doses Which Were Observed in a Urelumab Analogue in a Side-by-Side Comparison   ALG.APV-527 is a Novel Immunotherapeutic Bispecific Candidate Designed to Treat Multiple Solid Tumors Expressing 5T4, a Tumor-Restricted AntigenSeattle, WA and Lund, Sweden – June 10, 2020 – Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology

CELLINK and Lonza Join Forces to Offer Complete 3D Cell Culture Workflows

· CELLINK has collaborated with Lonza to offer a comprehensive 3-dimensional (3D) bioprinting solution designed to advance complete 3D cell culture workflows. · The solution combines CELLINK’s 3D bioprinting instruments and bioinks with Lonza’s primary cells and culture media, to meet the needs of cell biologists for enhanced bioprinting of complex 3D human tissue constructs. · Under the agreement, CELLINK will provide this complete solution through its global sales channels, supported by Lonza’s well-established logistics processes. Ginger Lohman, Biodispensing Product Manager,

FINAL RESULT OF AVIDLY PLC’S RIGHTS ISSUE

FINAL RESULT OF AVIDLY PLC’S RIGHTS ISSUE Avidly Plc, company release, 10 June 2020 at 4 pm EEST NOT TO BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY TO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER COUNTRY WHERE THE DISTRIBUTION OR PUBLICATION WOULD BE ILLEGAL. The final result of Avidly Plc’s (“Company” or “Avidly”) rights issue of maximum of 2,487,502 new shares (“Share Issue”) shows that 2,101,117 shares, corresponding to approximately 84.47 percent of the new shares offered (the “Offered Shares”), were subscribed

STRAX: STRAX RENEWS MOBILCOM-DEBITEL AGREEMENT

STRAX, the mobile accessories specialist, has renewed its contract with mobilcom-debitel for another four years. STRAX will supply approximately 550 stores and the online shop www.mobilcom-debitel.de with a broad range of products from its extensive portfolio of brands. STRAX will furthermore continue supporting the development and manufacturing of mobilcom-debitel’s own freenet brand.   “We are very happy to continue developing our long-standing partnership with mobilcom-debitel for another four years. In a relatively short period of time mobilcom-debitel has become one of STRAX largest

Resolutions passed by the Annual General Meeting of HKScan Corporation

HKScan Corporation             Stock Exchange Release      10 June 2020          15.45 EESTResolutions passed by the Annual General Meeting of HKScan Corporation HKScan Corporation’s Annual General Meeting, held on 10 June 2020 in Turku under special arrangements due to the COVID-19 pandemic, adopted the parent company’s and consolidated financial statements, and discharged the members of the Board of Directors and CEO from liability for the year 2019. A total of 39 shareholders were represented in the AGM, representing 46,670,804 shares and 148,270,804 votes. The AGM supported all

There are no items matching the current filter
There are no more items matching the current filter
Back to top